In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

HeartFlow closes $240mm Series E

Executive Summary

Cardiovascular device maker HeartFlow Inc. raised $240mm in its Series E financing from Wellington Management, Baillie Gifford, and returning shareholders. The company will use the funds for commercial expansion of its HeartFlow Analysis test that creates a computerized 3D model of the coronary arteries to assess heart disease. Additional funding will help with clinical trials and technology innovation.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • X-ray
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies